4-hydroxy-equilenin has been researched along with tamoxifen in 1 studies
Studies (4-hydroxy-equilenin) | Trials (4-hydroxy-equilenin) | Recent Studies (post-2010) (4-hydroxy-equilenin) | Studies (tamoxifen) | Trials (tamoxifen) | Recent Studies (post-2010) (tamoxifen) |
---|---|---|---|---|---|
32 | 0 | 0 | 20,630 | 2,227 | 6,256 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bolton, JL; Hua, Y; Liu, X; Pisha, E; van Breemen, RB; Yang, Y; Yao, J | 1 |
1 other study(ies) available for 4-hydroxy-equilenin and tamoxifen
Article | Year |
---|---|
Oxidative DNA damage induced by equine estrogen metabolites: role of estrogen receptor alpha.
Topics: Binding, Competitive; Breast Neoplasms; Cell Survival; Comet Assay; DNA Damage; DNA, Neoplasm; Dose-Response Relationship, Drug; Equilenin; Estradiol Congeners; Estrogen Receptor alpha; Female; Humans; Reactive Oxygen Species; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Tumor Cells, Cultured | 2002 |